May 6, 2017

PharmaMetrics Successfully Completes SOC 1 Security Audit

Examination Evaluated PharmaMetrics’ Data Security, Availability, and Processes

Philadelphia, PA, May 4, 2017 –PharmaMetrics, an IntegriChain company and leading provider analytics and services to optimizing market access, today announced it has successfully completed a Service Organization Controls (SOC 1) examination of its system of controls for calculating manufacturer rebate payments. CliftonLarsonAllen LLP performed the SOC 1 examination of PharmaMetrics following The American Institute of Certified Public Accountants (AICPA) Trust Services Principles and related criteria covering security, availability, and processing integrity.

About PharmaMetrics
PharmaMetrics is a leading provider of contract analytics, advisory services, and contract management outsourcing for managed markets and contracts and pricing teams at leading and emerging bio/pharma companies to optimize market access. PharmaMetrics is rated first in Contract Operations Service and first in Contract Effectiveness (Analytics) by Zensights, a leader in insights into critical biopharma vendor/supplier engagement issues and “Best in Class” vendor identification. Utilizing its deep expertise, the company delivers a market access platform comprising contract analytics, advisory services, and contract management outsourcing focused on driving optimal price, compliance, and operational efficiency. Specializing in payer and deal analysis, guidelines and processes guidance, and contract and rebate management, PharmaMetrics allows bio/pharma companies to scale their payer analytics and contracting functions to meet today’s complex commercial and government market access challenges. For more information, visit https://www.pharmametricsinc.com/.

About IntegriChain
IntegriChain is a rapidly growing healthcare technology company, offering the leading cloud for enriched data and analytics to optimize distribution, patient access, and market access for life sciences managed markets teams. Pharmaceutical, biopharm/specialty pharma, generics, and medtech suppliers leverage insights from IntegriChain’s unmatched factory-to-patient visibility to maximize patient access and to address critical risks throughout the patient journey and product life cycle. IntegriChain delivers the enriched data and analytics foundation for more efficient and service-oriented channel models for mature product categories as well as for innovative products that must balance significant therapeutic benefit with out-of-pocket costs and benefit hurdles. Today IntegriChain is the trusted partner for all top-10 bio/pharmaceutical companies, 17 of the top-20 life science companies, and more than 50 other suppliers, totaling more than $250 billion in annual US commerce. IntegriChain is backed by Accel-KKR, a leading Silicon Valley technology private equity firm. For more information, visit www.integrichain.com and our blog, and follow us on Twitter @IntegriChain and LinkedIn.

PharmaMetrics is a registered trademark of PharmaMetrics, Inc. IntegriChain is a registered trademark of IntegriChain Incorporated. All other trademarks are property of their respective owners.

Contact
Jennifer Guinan | Sage Strategic Marketing | 610.410.8111 | Jennifer@sagestrat.com